BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo K, Eid SA, Elzinga SE, Pacut C, Feldman EL, Hur J. Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy. Clin Epigenetics 2020;12:123. [PMID: 32787975 DOI: 10.1186/s13148-020-00913-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Savelieff MG, Feldman EL. Immune-mediated vincristine-induced neuropathy: Unlocking therapies. J Exp Med 2021;218:e20210286. [PMID: 33751022 DOI: 10.1084/jem.20210286] [Reference Citation Analysis]
2 Płatek T, Polus A, Góralska J, Raźny U, Dziewońska A, Micek A, Dembińska-Kieć A, Solnica B, Malczewska-Malec M. Epigenetic Regulation of Processes Related to High Level of Fibroblast Growth Factor 21 in Obese Subjects. Genes (Basel) 2021;12:307. [PMID: 33670024 DOI: 10.3390/genes12020307] [Reference Citation Analysis]
3 Kim DY, Kim JM. Multi-omics integration strategies for animal epigenetic studies - A review. Anim Biosci 2021;34:1271-82. [PMID: 33902167 DOI: 10.5713/ab.21.0042] [Reference Citation Analysis]
4 Luo J, Wang X, Yuan L, Guo L. Genome‑wide profiling of DNA methylation and gene expression unravel the epigenetic landscape in diabetes-related hypothyroidism. Clin Epigenetics 2021;13:123. [PMID: 34092241 DOI: 10.1186/s13148-021-01109-2] [Reference Citation Analysis]
5 Zhang X, Zhao S, Yuan Q, Zhu L, Li F, Wang H, Kong D, Hao J. TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression. Cell Death Dis 2021;12:642. [PMID: 34162834 DOI: 10.1038/s41419-021-03930-2] [Reference Citation Analysis]
6 Płatek T, Polus A, Góralska J, Raźny U, Gruca A, Kieć-Wilk B, Zabielski P, Kapusta M, Słowińska-Solnica K, Solnica B, Malczewska-Malec M, Dembińska-Kieć A. DNA methylation microarrays identify epigenetically regulated lipid related genes in obese patients with hypercholesterolemia. Mol Med 2020;26:93. [PMID: 33028190 DOI: 10.1186/s10020-020-00220-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Jankovic M, Novakovic I, Nikolic D, Mitrovic Maksic J, Brankovic S, Petronic I, Cirovic D, Ducic S, Grajic M, Bogicevic D. Genetic and Epigenomic Modifiers of Diabetic Neuropathy. Int J Mol Sci 2021;22:4887. [PMID: 34063061 DOI: 10.3390/ijms22094887] [Reference Citation Analysis]
8 Eid SA, Hinder LM, Zhang H, Eksi R, Nair V, Eddy S, Eichinger F, Park M, Saha J, Berthier CC, Jagadish HV, Guan Y, Pennathur S, Hur J, Kretzler M, Feldman EL, Brosius FC. Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects. FASEB J 2021;35:e21467. [PMID: 33788970 DOI: 10.1096/fj.202002387R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Azarova IE, Klyosova EY, Kolomoets II, Polonikov AV. Polymorphic Variants of the Neutrophil Cytosolic Factor 2 Gene: Associations with Susceptibility to Type 2 Diabetes Mellitus and Cardiovascular Autonomic Neuropathy. Russ J Genet 2022;58:593-602. [DOI: 10.1134/s1022795422050039] [Reference Citation Analysis]